Shared on27 Aug 25Fair value Increased 3.70%
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.
Shared on29 Jul 25Fair value Decreased 6.60%
The downward revision in Mycronic's analyst price target reflects notably softer outlooks for both revenue growth and net profit margin, resulting in a reduced fair value from SEK245.73 to SEK229.50. What's in the News Mycronic increased its 2025 net sales guidance to SEK 7.5 billion, restoring its original outlook.
Shared on01 May 25Fair value Decreased 9.16%
AnalystConsensusTarget has decreased revenue growth from 6.2% to 3.7%.
Shared on23 Apr 25Fair value Decreased 1.33%
AnalystConsensusTarget has decreased revenue growth from 8.3% to 6.2% and decreased shares outstanding growth rate from 0.0% to -0.0%.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 19%
AnalystConsensusTarget has increased revenue growth from 3.5% to 8.3% and increased shares outstanding growth rate from -0.0% to 0.0%.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 0.16%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Decreased 46%
AnalystConsensusTarget has increased revenue growth from 6.3% to 9.0%.